APA (7th ed.) Citation

A, M., F, B., R, H., S, M., F, C., G, R., . . . F, M. (2018). Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration. Nature communications, 9(1), 4098. https://doi.org/10.1038/s41467-018-06621-3

Chicago Style (17th ed.) Citation

A, Meliani, et al. "Antigen-selective Modulation of AAV Immunogenicity with Tolerogenic Rapamycin Nanoparticles Enables Successful Vector Re-administration." Nature Communications 9, no. 1 (2018): 4098. https://doi.org/10.1038/s41467-018-06621-3.

MLA (9th ed.) Citation

A, Meliani, et al. "Antigen-selective Modulation of AAV Immunogenicity with Tolerogenic Rapamycin Nanoparticles Enables Successful Vector Re-administration." Nature Communications, vol. 9, no. 1, 2018, p. 4098, https://doi.org/10.1038/s41467-018-06621-3.